FOSAPREPITANT

N/A

Manufactured by Actavis Pharma, Inc.

13,437 FDA adverse event reports analyzed

Last updated: 2026-04-15

About FOSAPREPITANT

FOSAPREPITANT is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Actavis Pharma, Inc.. The most commonly reported adverse reactions for FOSAPREPITANT include DYSPNOEA, INFUSION RELATED REACTION, ALOPECIA, FATIGUE, HYPERSENSITIVITY. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for FOSAPREPITANT.

Top Adverse Reactions

DYSPNOEA293 reports
INFUSION RELATED REACTION245 reports
ALOPECIA228 reports
FATIGUE212 reports
HYPERSENSITIVITY206 reports
PYREXIA202 reports
ARTHRALGIA201 reports
CONFUSIONAL STATE197 reports
DUODENAL ULCER PERFORATION193 reports
NAUSEA189 reports
DISCOMFORT186 reports
CONTUSION185 reports
GLOSSODYNIA185 reports
ABDOMINAL DISCOMFORT184 reports
ARTHROPATHY183 reports
FOLLICULITIS183 reports
HEPATIC ENZYME INCREASED183 reports
BLISTER182 reports
PRURITUS182 reports
HELICOBACTER INFECTION181 reports
CONDITION AGGRAVATED177 reports
PAIN177 reports
RASH177 reports
STOMATITIS177 reports
GASTROINTESTINAL DISORDER176 reports
HAND DEFORMITY176 reports
ANTI CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE175 reports
IMPAIRED HEALING175 reports
ILL DEFINED DISORDER173 reports
INFECTION168 reports
PEMPHIGUS166 reports
MUSCLE INJURY165 reports
GENERAL PHYSICAL HEALTH DETERIORATION164 reports
PERICARDITIS163 reports
JOINT SWELLING162 reports
LOWER RESPIRATORY TRACT INFECTION162 reports
SYSTEMIC LUPUS ERYTHEMATOSUS162 reports
WEIGHT INCREASED162 reports
SINUSITIS160 reports
INSOMNIA158 reports
NASOPHARYNGITIS158 reports
PERIPHERAL SWELLING158 reports
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE158 reports
IRRITABLE BOWEL SYNDROME157 reports
SYNOVITIS155 reports
SWELLING154 reports
WOUND153 reports
RHEUMATOID ARTHRITIS152 reports
INJURY149 reports
DIARRHOEA147 reports
VOMITING138 reports
ABDOMINAL PAIN134 reports
DIZZINESS128 reports
OFF LABEL USE125 reports
CHEST PAIN122 reports
ANXIETY116 reports
ASTHENIA114 reports
SLEEP DISORDER114 reports
DECREASED APPETITE110 reports
CONTRAINDICATED PRODUCT ADMINISTERED109 reports
HEADACHE105 reports
HYPERTENSION101 reports
ABDOMINAL PAIN UPPER98 reports
FEELING HOT97 reports
ASTHMA96 reports
DRUG HYPERSENSITIVITY96 reports
MATERNAL EXPOSURE DURING PREGNANCY93 reports
AUTOIMMUNE DISORDER92 reports
DELIRIUM90 reports
PNEUMONIA90 reports
FLUSHING89 reports
DRY MOUTH88 reports
BURSITIS86 reports
BREAST CANCER STAGE III85 reports
MALAISE85 reports
DEPRESSION84 reports
HYPOAESTHESIA84 reports
BLOOD CHOLESTEROL INCREASED83 reports
AMNESIA82 reports
CROHN^S DISEASE81 reports
ADJUSTMENT DISORDER WITH DEPRESSED MOOD80 reports
C REACTIVE PROTEIN ABNORMAL80 reports
COLITIS ULCERATIVE80 reports
DISLOCATION OF VERTEBRA80 reports
ARTHRITIS79 reports
BONE EROSION79 reports
FIBROMYALGIA78 reports
DYSPEPSIA77 reports
FACET JOINT SYNDROME77 reports
DEEP VEIN THROMBOSIS POSTOPERATIVE75 reports
FEBRILE NEUTROPENIA75 reports
URTICARIA74 reports
WEIGHT DECREASED74 reports
HEPATIC CIRRHOSIS73 reports
MUSCLE SPASMS73 reports
GAIT DISTURBANCE72 reports
EAR INFECTION70 reports
FREQUENT BOWEL MOVEMENTS70 reports
HYPERCHOLESTEROLAEMIA70 reports
TYPE 2 DIABETES MELLITUS70 reports

Report Outcomes

Out of 1,556 classified reports for FOSAPREPITANT:

Serious 88.2%Non-Serious 11.8%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female891 (64.9%)
Male478 (34.8%)
Unknown3 (0.2%)

Reports by Age

Age 44139 reports
Age 6143 reports
Age 6041 reports
Age 7240 reports
Age 5135 reports
Age 5934 reports
Age 6234 reports
Age 7134 reports
Age 5430 reports
Age 5828 reports
Age 7028 reports
Age 6926 reports
Age 6824 reports
Age 5623 reports
Age 6323 reports
Age 6623 reports
Age 6422 reports
Age 6522 reports
Age 6722 reports
Age 4521 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with FOSAPREPITANT?

This profile reflects 13,437 FDA FAERS reports that mention FOSAPREPITANT. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for FOSAPREPITANT?

Frequently reported terms in FAERS include DYSPNOEA, INFUSION RELATED REACTION, ALOPECIA, FATIGUE, HYPERSENSITIVITY, PYREXIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures FOSAPREPITANT?

Labeling and FAERS entries often list Actavis Pharma, Inc. in connection with FOSAPREPITANT. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.